Teva Says It Doesn't Belong In Pay-For-Delay MDL
Teva Pharmaceutical Industries Ltd. has asked a Connecticut federal court to be dismissed from antitrust class actions alleging a pay-for-delay scheme over a generic version of stroke drug Aggrenox, saying it...To view the full article, register now.
Already a subscriber? Click here to view full article